54 related articles for article (PubMed ID: 23228448)
1. Foscarnet reduces FGF2-induced proliferation of human umbilical vein endothelial cells and has antineoplastic activity against human anaplastic thyroid carcinoma cells.
Rose K
Biomed Pharmacother; 2013 Feb; 67(1):53-7. PubMed ID: 23228448
[TBL] [Abstract][Full Text] [Related]
2. Interaction of clodronate with fibroblast growth factor 2 reduces FGF2-activity in endothelial cells.
Rose K; Finger IE; Ferenz KB
Biomed Pharmacother; 2011 Feb; 65(1):46-51. PubMed ID: 21177067
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
4. Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells.
Zaragosi LE; Ailhaud G; Dani C
Stem Cells; 2006 Nov; 24(11):2412-9. PubMed ID: 16840552
[TBL] [Abstract][Full Text] [Related]
5. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
[TBL] [Abstract][Full Text] [Related]
6. The nucleotide analog cidofovir suppresses basic fibroblast growth factor (FGF2) expression and signaling and induces apoptosis in FGF2-overexpressing endothelial cells.
Liekens S; Gijsbers S; Vanstreels E; Daelemans D; De Clercq E; Hatse S
Mol Pharmacol; 2007 Mar; 71(3):695-703. PubMed ID: 17158200
[TBL] [Abstract][Full Text] [Related]
7. Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.
Shiang CY; Qi Y; Wang B; Lazar V; Wang J; Fraser Symmans W; Hortobagyi GN; Andre F; Pusztai L
Breast Cancer Res Treat; 2010 Oct; 123(3):747-55. PubMed ID: 20024612
[TBL] [Abstract][Full Text] [Related]
8. Similar expression to FGF (Sef) reduces endometrial adenocarcinoma cells proliferation via inhibiting fibroblast growth factor 2-mediated MAPK/ERK signaling pathway.
Zhang H; Zhao X; Yan L; Li M
Gynecol Oncol; 2011 Sep; 122(3):669-74. PubMed ID: 21663947
[TBL] [Abstract][Full Text] [Related]
9. Two distinct signalling pathways are involved in FGF2-stimulated proliferation of choriocapillary endothelial cells: a comparative study with VEGF.
Zubilewicz A; Hecquet C; Jeanny JC; Soubrane G; Courtois Y; Mascarelli F
Oncogene; 2001 Mar; 20(12):1403-13. PubMed ID: 11313884
[TBL] [Abstract][Full Text] [Related]
10. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
[TBL] [Abstract][Full Text] [Related]
11. GNA11 differentially mediates fibroblast growth factor 2- and vascular endothelial growth factor A-induced cellular responses in human fetoplacental endothelial cells.
Zou QY; Zhao YJ; Li H; Wang XZ; Liu AX; Zhong XQ; Yan Q; Li Y; Zhou C; Zheng J
J Physiol; 2018 Jun; 596(12):2333-2344. PubMed ID: 29659033
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
[TBL] [Abstract][Full Text] [Related]
14. Neural cell adhesion molecule regulates the cellular response to fibroblast growth factor.
Francavilla C; Loeffler S; Piccini D; Kren A; Christofori G; Cavallaro U
J Cell Sci; 2007 Dec; 120(Pt 24):4388-94. PubMed ID: 18042627
[TBL] [Abstract][Full Text] [Related]
15. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
16. Novel cross talk between MEK and S6K2 in FGF-2 induced proliferation of SCLC cells.
Pardo OE; Arcaro A; Salerno G; Tetley TD; Valovka T; Gout I; Seckl MJ
Oncogene; 2001 Nov; 20(52):7658-67. PubMed ID: 11753643
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway.
Finetti F; Donnini S; Giachetti A; Morbidelli L; Ziche M
Circ Res; 2009 Sep; 105(7):657-66. PubMed ID: 19713533
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
Presta M; Oreste P; Zoppetti G; Belleri M; Tanghetti E; Leali D; Urbinati C; Bugatti A; Ronca R; Nicoli S; Moroni E; Stabile H; Camozzi M; Hernandez GA; Mitola S; Dell'Era P; Rusnati M; Ribatti D
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):71-6. PubMed ID: 15514208
[TBL] [Abstract][Full Text] [Related]
19. Adenine nucleotides inhibit proliferation of the human lung adenocarcinoma cell line LXF-289 by activation of nuclear factor kappaB1 and mitogen-activated protein kinase pathways.
Schäfer R; Hartig R; Sedehizade F; Welte T; Reiser G
FEBS J; 2006 Aug; 273(16):3756-67. PubMed ID: 16911524
[TBL] [Abstract][Full Text] [Related]
20. Culture supernatants of breast cancer cell line MDA-MB-231 treated with parthenolide inhibit the proliferation, migration, and lumen formation capacity of human umbilical vein endothelial cells.
Li CJ; Guo SF; Shi TM
Chin Med J (Engl); 2012 Jun; 125(12):2195-9. PubMed ID: 22884152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
